OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
6630
Results
Show all
Save search
Copy query
Show results for
Unknown
(5729)
Genomics
(465)
Transcriptomics
(312)
Proteomics
(89)
Other
(17)
Models
(9)
Methylation profiling
(6)
Clinical
(2)
Metabolomics
(1)
Organisms
Homo sapiens
(211)
Mus musculus
(188)
Aerococcus urinae NBRC 15544 = CCUG 36881
(59)
Andropogon gerardi
(59)
Bacteria
(59)
Bartonella quintana JK 31
(59)
Canis lupus familiaris
(59)
Cnidaria
(59)
Ectopseudomonas oleovorans CECT 5344
(59)
Ensifer adhaerens
(59)
Globicatella sanguinis
(59)
Halictus scabiosae
(59)
Human immunodeficiency virus 1
(59)
Mesocricetus auratus
(59)
Methylohalobius crimeensis 10Ki
(59)
Miscanthus x giganteus
(59)
Mus musculus
(59)
Panicum virgatum
(59)
Pseudomonas aeruginosa SJTD-1
(59)
Rabies virus Nishigahara RCEH
(59)
Rattus norvegicus
(59)
Rattus rattus
(59)
Rhodococcus jostii RHA1
(59)
Rattus norvegicus
(5)
Peromyscus leucopus
(2)
Macaca mulatta
(2)
HIV-1 group M
(1)
Borreliella burgdorferi
(1)
Macaca fascicularis
(1)
Mus
(1)
Organisms
Mus musculus
(173)
Homo sapiens
(153)
Macaca mulatta
(2)
Mycobacterium intracellulare subsp. intracellulare MTCC 9506
(1)
Mycobacterium intracellulare subsp. intracellulare
(1)
Macaca fascicularis
(1)
Mus
(1)
Rattus norvegicus
(1)
unidentified
(1)
Repository
ENA
(428)
geo
(331)
pride
(59)
biostudies-arrayexpress
(33)
EGA
(14)
iProX
(14)
BioModels
(9)
MassIVE
(7)
jPOST
(3)
MetaboLights
(1)
Tissue
Cell culture
(13)
Brain
(4)
Cell suspension culture
(3)
Leukocyte
(3)
Myeloid cell
(3)
Blood
(2)
JURKAT cell
(2)
Liver
(2)
Macrophage
(2)
Myeloid cell line
(2)
Peripheral blood mononuclear cell
(2)
Permanent cell line cell
(2)
T cell
(2)
Acute myeloid leukemia cell line
(1)
B cell
(1)
B-cell lymphoma/leukemia 11B
(1)
B-lymphoblastoid cell line
(1)
Blood cell
(1)
Blood circulation
(1)
Blood plasma
(1)
Blood platelet
(1)
Bone marrow
(1)
Central nervous system
(1)
Cerebrospinal fluid
(1)
Cerebrospinal fluid secretion
(1)
Cholangiocarcinoma cell line
(1)
Colon
(1)
Dendritic cell
(1)
Escherichia coli metabolite
(1)
Ewing's sarcoma cell
(1)
Disease
Acute myeloid leukemia
(4)
Brain cancer
(3)
Brain glioblastoma multiforme
(3)
Disease free
(3)
Breast cancer
(2)
Multiple myeloma
(2)
Large cell carcinoma
(1)
Stomach Neoplasms
(1)
Colorectal Neoplasms
(1)
Acute leukemia
(1)
B-cell acute lymphoblastic leukemia
(1)
Chronic lymphocytic leukemia
(1)
Chronic myeloid leukemia
(1)
Colon adenocarcinoma
(1)
Colon cancer
(1)
Ewing sarcoma of bone
(1)
Glioblastoma
(1)
Hepatitis B
(1)
Hepatocellular carcinoma
(1)
Lung cancer
(1)
Lymphoma
(1)
Malignant neoplasm of ovary
(1)
Melanoma
(1)
Multiple sclerosis
(1)
Neuroblastoma
(1)
Skin cancer
(1)
Skin melanoma
(1)
Technology Type
Mass Spectrometry
(59)
Shotgun proteomics
(24)
Bottom-up proteomics
(12)
Affinity purification coupled with mass spectrometry proteomics
(9)
Data-dependent acquisition
(8)
Data-independent acquisition
(4)
Gel-based experiment
(4)
Chemical cross-linking coupled with mass spectrometry proteomics
(3)
Immunopeptidomics
(3)
SWATH MS
(3)
NextSeq 500, ILLUMINA
(1)
ILLUMINA, NextSeq 500, HiSeq X Ten
(1)
ILLUMINA, Illumina HiSeq 2500
(1)
Mass spectrometry
(1)
DiaPASEF
(1)
Proteogenomics
(1)
SRM/MRM
(1)
Top-down proteomics
(1)
Instrument Platform
Illumina NovaSeq 6000
(2)
Q Exactive
(2)
NextSeq 500
(1)
Orbitrap Eclipse
(1)
Orbitrap Exploris 480
(1)
Orbitrap Fusion
(1)
Orbitrap Fusion ETD
(1)
Orbitrap Fusion Lumos
(1)
Q Exactive HF
(1)
QExactive LCMS
(1)
Liquid Chromatography MS - negative - hilic
(1)
Liquid Chromatography MS - positive - hilic
(1)
Publication Date
2026
(82)
2024
(78)
2025
(74)
2022
(50)
2023
(40)
2021
(24)
2020
(18)
2019
(17)
2016
(11)
2017
(10)
2015
(7)
2013
(7)
2018
(6)
2010
(6)
2008
(5)
2012
(4)
2011
(3)
2009
(3)
2014
(1)
UNIPROT ID/AC
C4NUM1
(1)
A2RSY7
(1)
Q9ES17
(1)
P25445
(1)
P48023
(1)
CHEBI ID
CHEBI:17089
(1)
Metabolite Name
L-4-Hydroxyglutamate_semialdehyde
(1)
Val-Cys
(1)
Nicotinamide mononucleotide (NMN)
(1)
Methyl_2-(10-heptadecenyl)-6-hydroxybenzoate
(1)
1,2-Dilinoleoyl-sn-glycero-3-phosphoethanolamine
(1)
L-Menthone_1,2-glycerol_ketal
(1)
Tetradecadienoylcarnitine (Car(14:2))
(1)
Phthalimide
(1)
4-Methyl-1H-pyrazole
(1)
2-Docosahexaenoyl-1-palmitoyl-sn-glycero-3-phosphoethanolamine
(1)
1-Aminocyclopentanecarboxylic acid
(1)
1-Palmitoyl-2-glutaryl phosphatidylcholine
(1)
1-Lignoceroyl-2-hydroxy-sn-glycero-3-phosphocholine
(1)
1-(1Z-Octadecenyl)-sn-glycero-3-phosphocholine
(1)
1,2-Diarachidonoyl-sn-glycero-3-phosphocholine
(1)
1,2-Di-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phosphocholine
(1)
Heptenoylcarnitine (Car(7:1))
(1)
1-Behenoyl-2-hydroxy-sn-glycero-3-phosphocholine
(1)
Dodecenoylcarnitine (Car(12:1))
(1)
Heptanoylcarnitine (Car(7:0))
(1)
N-Lauroyl-D-erythro-sphingosylphosphorylcholine
(1)
3-Amino-2-oxazolidinone
(1)
N-Methyl-L-threonine
(1)
N-Nervonoyl-D-erythro-sphingosylphosphorylcholine
(1)
Ala-Met
(1)
His-Glu
(1)
Pimonidazole
(1)
His-Ser
(1)
Gly-Pro-Arg
(1)
Sapanisertib
(1)
First Public Date
2026
(91)
2024
(80)
2025
(78)
2022
(44)
2023
(40)
2021
(25)
2019
(21)
2020
(17)
2017
(12)
2014
(8)
2016
(4)
2018
(3)
2015
(3)
2013
(2)
Modelling Approach
Ordinary differential equation model
(8)
Study status
Completed
(2)
Lab affiliation
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
(3)
Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany
(2)
Dept. of Laboratory Medicine University of California, San Francisco, USA
(2)
IRIC-Université de Montréal
(2)
Immunology Research Center, National Health Research Institutes, Zhunan, Taiwan.
(2)
1 Department of Computer Science, Hanyang University, Seoul 04763, Republic of Korea 2 Institute for Artificial Intelligence Research, Hanyang University, Seoul 04763, Republic of Korea
(1)
1. Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Germany 2. Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tübingen, Germany 3. Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Germany 4. German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), partner site Tübingen, Germany
(1)
Aix Marseille Univ, CNRS, INSERM, Institut Paoli Calmettes - Marseille Proteomics
(1)
Assistant Professor Department of Food Science & Technology Food Allergy Research & Resource Program University of Nebraska-Lincoln
(1)
Biomolecular Mass Spectrometry and Proteomics, Utrecht University
(1)
Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver V5Z 1L3, Canada
(1)
Cancer Precision Medicine Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, QLD, 4006, Australia.
(1)
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences Lazarettgasse 14, AKH BT 25.3 1090 Vienna, Austria
(1)
Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee
(1)
Center for Proteomics and Metabolomics, LUMC, Leiden, The Netherlands
(1)
Centro de Investigación Médica Aplicada (CIMA), Clínica Universidad de Navarra (CUN)
(1)
Children's Hospital of Philadelphia
(1)
Department of Biology, University of Rome Tor Vergata, Rome, Italy Telethon Institute of Genetics and Medicine (TIGEM), Pozzuoli, Naples, Italy
(1)
Department of Chemical & Systems Biology Stanford University USA
(1)
Department of Clinical Sciences Lund, Section of Oncology, Lund University, Lund 221 85, Sweden
(1)
Department of Haematology, University of Cambridge
(1)
Department of Integrated Immunobiology Duke School of Medicine Durham, NC, USA
(1)
Department of Laboratory Medicine Department of Bioengineering and Therapeutic Sciences University of California, San Francisco
(1)
Department of Life Sciences, POSTECH, Pohang, Republic of Korea
(1)
Department of Medicine, Penn State Cancer Institute, Penn State College of Medicine, Hershey, PA.
(1)
Department of Molecular Biology; Kang Lab; Princeton University, Princeton, NJ, USA
(1)
Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine or College of Pharmacy, Seoul National University, Republic of Korea
(1)
Department of Pathology, Saint Louis University, St. Louis, Missouri, United States
(1)
Department of Pathology, School of Medicine, Saint Louis University, United States, St. Louis VA Medical Center(VHA), United States
(1)
Department of Peptide-based Immunotherapy, University and University Hospital Tübingen, Tübingen, Germany
(1)
Tags
xref:PubMed:39970333
(5)
xref:PubMed:35614224
(4)
xref:PubMed:42760560
(4)
xref:PubMed:36516256
(3)
xref:PubMed:31046839
(3)
xref:PubMed:42481500
(3)
xref:PubMed:27923825
(3)
xref:PubMed:35978192
(3)
xref:PubMed:37350973
(3)
xref:PubMed:41423270
(3)
xref:PubMed:41617394
(3)
xref:PubMed:39888981
(3)
xref:PubMed:37352379
(2)
xref:PubMed:36593065
(2)
xref:PubMed:37561398
(2)
xref:PubMed:34440912
(2)
xref:PubMed:32603315
(2)
xref:PubMed:32762727
(2)
xref:PubMed:31537801
(2)
xref:PubMed:35738508
(2)
xref:PubMed:34552178
(2)
xref:PubMed:39358361
(2)
xref:PubMed:39070650
(2)
xref:PubMed:39613742
(2)
xref:PubMed:35119937
(2)
xref:PubMed:40768602
(2)
xref:PubMed:40382385
(2)
xref:PubMed:39292817
(2)
xref:PubMed:41390797
(2)
xref:PubMed:42364978
(2)
Keyword
HER2/neu
(1)
IHC 1+
(1)
BVAC
(1)
Cellid
(1)
B-cell
(1)
Monocyte
(1)
Immunotherapeutic vaccine
(1)
IsPrivate
False
(9)
Submitter Keywords
Immuno-oncology
(6)
Classification
bacteria
(2)
Study type
Transcription profiling by array
(23)
Proteomic profiling by array
(3)
RNA-seq of coding RNA
(3)
RNA-seq of coding RNA from single cells
(2)
Animal - One-color microarray
(1)
RNA-seq of total RNA
(1)
Observational
(1)
Interventional
(1)
Release Date
2022
(941)
2023
(823)
2021
(671)
2024
(647)
2025
(642)
2020
(463)
2019
(311)
2018
(251)
2017
(228)
2016
(202)
2015
(131)
2014
(103)
2026
(97)
2013
(79)
2012
(50)
2011
(32)
2010
(27)
2009
(24)
2008
(14)
2006
(7)
2007
(5)
2005
(5)
2004
(3)
2002
(3)
2000
(2)
2001
(1)
Location
South Korea
(1)
Italy
(1)
Previous
page
1 / 663
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
663
Next
page
Sort
by:
Relevance
Page size
10
Immunotherapeutic targeting of surfaceome heterogeneity in AML
Immunotherapeutic targeting of surfaceome heterogeneity in AML
PRJNA1010863
|
ENA
Cite
MAGEA antigens as immunotherapeutic targets for advanced osteosarcoma
MAGEA antigens as immunotherapeutic targets for advanced osteosarcoma
PRJNA993578
|
ENA
Cite
ZNF165 as a potential novel immunotherapeutic target for gastric cancer
ZNF165 as a potential novel immunotherapeutic target for gastric cancer
PRJNA866849
|
ENA
Cite
Combinatorial Immunotherapeutic Strategies in Liver Cancer
Combinatorial Immunotherapeutic Strategies in Liver Cancer
PRJNA1257769
|
ENA
Cite
Immunotherapeutic effects of intratumoral nanoplexed Poly I:C
Immunotherapeutic effects of intratumoral nanoplexed Poly I:C
PRJNA476961
|
ENA
Cite
Defining the Inflammation and Immunity Transcriptome in Severe Malarial Anemia for Immunotherapeutic Discovery
Defining the Inflammation and Immunity Transcriptome in Severe Malarial Anemia for Immunotherapeutic Discovery
PRJNA1074811
|
ENA
Cite
Immunotherapeutic Approaches for Treating Hepatocellular Carcinoma.
Not available
S-EPMC9599666
|
biostudies-literature
Cite
Immunotherapeutic approaches to ovarian cancer treatment.
Not available
S-EPMC4372273
|
biostudies-literature
Cite
Immunotherapeutic Agents for Intratumoral Immunotherapy.
Not available
S-EPMC10674963
|
biostudies-literature
Cite
ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis
ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis
PRJNA767108
|
ENA
Cite
Previous
page
1 / 663
You're on page
1
page
2
page
3
page
4
page
5
page
...
page
663
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets